Mycoplasma pneumonia epidemiology and demographics

Jump to: navigation, search

Pneumonia Main Page

Mycoplasma pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Mycoplasma pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycoplasma pneumonia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mycoplasma pneumonia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycoplasma pneumonia epidemiology and demographics

CDC on Mycoplasma pneumonia epidemiology and demographics

Mycoplasma pneumonia epidemiology and demographics in the news

Blogs on Mycoplasma pneumonia epidemiology and demographics

Directions to Hospitals Treating Mycoplasma pneumonia

Risk calculators and risk factors for Mycoplasma pneumonia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In the USA, the incidence of Mycoplasma pneumonia is approximately 600 per 100,000 individuals.[1] Patients younger than 40 years of age (especially between 5 and 20 years of age) are more commonly affected with Mycoplasma pneumonia.[1] In contrast, Mycoplasma pneumonia is less common (but still incident) among children < 5 years of age or adults > 40-60 years of age. There is no gender predilection to the development of Mycoplasma pneumonia. The incidence of Mycoplasma pneumonia is higher in regions with temperate climate during the Summer and Fall.[2]

Epidemiology and Demographics

Incidence

  • In the USA, the incidence of Mycoplasma pneumonia is approximately 600 per 100,000 individuals.[1]
  • It is estimated that approximately 2 million cases of M. pneumoniae infection occur annually and account for approximately 100,000 hospitalizations.[1]
  • Mycoplasma pneumonia accounts for approximately 1% to 20% of cases of community-acquired pneumonia.[3]

Age

  • Patients younger than 40 years of age are more commonly affected with Mycoplasma pneumonia.[1]
  • Mycoplasma pneumonia is especially common among individuals between 5 and 20 years of age.[1]
  • Mycoplasma pneumonia is less common (but still incident) among children < 5 years of age or adults > 40-60 years of age.

Gender

  • There is no gender predilection to the development of Mycoplasma pneumonia.[1]

Geographical and Seasonal Distribution

  • The incidence of Mycoplasma pneumonia is higher in regions with temperate climate.[2]
  • The incidence of Mycoplasma pneumonia is higher in Summer and Fall (between June and November).[2]


References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Mycoplasma pneumoniae infection - Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/pneumonia/atypical/mycoplasma/hcp/disease-specifics.html Accessed on Feb 10 2016
  2. 2.0 2.1 2.2 Dey AB, Chaudhry R, Kumar P, Nisar N, Nagarkar KM (2000). "Mycoplasma pneumoniae and community-acquired pneumonia". Natl Med J India. 13 (2): 66–70. PMID 10835852.
  3. Koyama H, Honda K, Okuda K, Tsuchiya K, Tanaka S, Kawasaki H (1991). "[Predictive factors of etiologic agents of community-acquired pneumonia presenting at a district general hospital]". Nihon Kyobu Shikkan Gakkai Zasshi. 29 (9): 1111–8. PMID 1753538.

Linked-in.jpg